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Abstract: Rhinosinusitis (RS) is a common disease in children, significantly affecting their quality
of life. Chronic rhinosinusitis (CRS) is frequently linked to other respiratory diseases, including
asthma. Children affected by CRS may be candidates for surgery in the case of failure of maximal
medical therapy comprising three to six weeks of broad-spectrum systemic antibiotics with adjunctive
therapies. Although endoscopic sinus surgery (ESS) is the surgical treatment of choice in adult patients
with CRS, different surgical procedures are scheduled for refractory paediatric CRS and include
adenoidectomy, paediatric ESS (PESS), and balloon catheter sinuplasty (BCS). The present paper
discusses the indications and limitations of each treatment option in children with CRS. Given the
amount of current evidence, it is reasonable to suggest that, in young and otherwise healthy children
with refractory CRS, an adenoidectomy (eventually combined with BCS) should be offered as the
first-line surgical treatment. Nevertheless, this approach may be considered ineffective in some
patients who should be candidates for traditional ESS. In older children, those with asthma, or in the
case of peculiar conditions, traditional ESS should be considered as the primary treatment.
Keywords: rhinosinusitis; children; surgery; adenoidectomy; balloon sinuplasty; endoscopic
sinus surgery
1. Introduction and Anatomic Considerations
Rhinosinusitis (RS) is a common disease in children, significantly affecting the patients’ quality of
life [1,2], and disease complications requiring urgent treatment may occur.
RS is defined as the presence of two or more symptoms, one of which should be either nasal
blockage/obstruction/congestion or nasal discharge (with or without facial pain/pressure and cough),
and either endoscopic signs (i.e., nasal polyps and/or mucopurulent discharge from the middle
meatus and/or oedema/mucosal obstruction in the middle meatus) and/or symptomatic changes
observed through maxillo-facial computed tomography (i.e., mucosal changes within the ostiomeatal
complex and/or sinuses); chronic RS (CRS) occurs in the case of symptom persistence for more than
12 weeks [3]. CRS is a heterogeneous disease in adults, as different phenotypes and endotypes (i.e.,
biological subtypes defined by corresponding biomarkers and peculiar responsiveness to some medical
treatments) may be identified [4].
Paranasal sinuses are air-filled cavities lined by pseudostratified ciliated epithelium which is in
continuation with the nasal cavity. Homestasis of sinonasal drainage is substained by three main
factors: the patency of the sinusal obstia, the presence of an adequate and active mucous production,
and an effective ciliary function. The mucocicilary clearance transports sinusal secretions through
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the sinusal obstia into the nasal cavity. The ostiomeatal complex (Figure 1) is an important area
of sinusal drainage placed in the middle meatus where secretions from the maxillary, the anterior
ethmoid, and the frontal sinuses converge. It is composed by the natural obstium of the maxillary sinus,
the infundibulum, the uncinated process, the hiatus semilunaris, and the ethmoid bulla (Figure 1).
On the other hand, secretions from the posterior ethmoid and the sphenoid sinuses are directed through
the sphenoethmoidal recess, placed in the superior meatus.
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Viral upper respiratory tract infections are frequently inciting events, as they induce a 
transitory ciliostasis, predisposing to bacterial overgrowth. Possible causative factors are allergic 
and nonallergic rhinitis, airway pollution, smoke exposure, and prolonged nasotracheal tube 
placement [5]. Moreover, underlying systemic diseases may act as predisposing factors for the 
development of CRS with or without nasal polyps [6,7].  
Additionally, some anatomic anomalies of the ostiomeatal complex (Figure 1) or 
sphenoethmoidal recess impairing sinonasal drainage can be causative factors mainly in chronic or 
recurrent disease. The presence of hypertrophic and super-infected adenoidal pads may favour the 
development of paediatric CRS, acting as an infectious focus. 
Children affected by CRS may be candidates to surgery in case of failure of maximal medical 
therapy including three to six weeks of broad-spectrum systemic antibiotics with adjunctive 
therapies [8–15]. Although endoscopic sinus surgery (ESS) is the surgical treatment of choice in adult 
patients with CRS, different surgical procedures are scheduled for refractory paediatric CRS and 
include adenoidectomy, paediatric ESS (PESS), and balloon catheter sinuplasty (BCS) [8–11,13–15]. 
In 2012, the European Position Paper on RS and Nasal Polyps designed a therapeutic algorithm for 
the surgical treatment of paediatric RS, proposing adenoidectomy with possible antral irrigation or 
maxillary BCS as first-line treatment, and ESS as a second option in the case of failure [3].  
In the case of complicated disease during acute exacerbations, surgical treatment using ESS 
and/or an external approach depending on the location should be used in patients with 
subperiosteal abscess (SPA), orbital abscess or intracranial complications under an emergency 
setting. Surgery should also be considered if no improvement is observed 24–48 h after parenteral 
antibiotic treatment, in the case of multiple bacterial infections, and in children aged >9 years or 
those with known immunodeficiency [16]. In patients with a small SPA without impaired visual 
acuity or increased intra-ocular pressure, surgery can be considered a second step in the case of 
worsening of ophthalmological findings or no improvement after 48 h [16]. 
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surgery can be considered a second step in the case of worsening of ophthalmological findings or no
improvement after 48 h [16].
The present paper provides an overview on surgical options actually available to treat children
with CRS.
2. Methods
Pertinent studies published up to 1 February 2019 and concerning the role of surgery in paediatric
CRS were selected by ST after a MEDLINE search (accessed via PubMed) based on the following
terms: “chronic rhinosinusitis AND children AND surgery”, “chronic rhinosinusitis AND children
AND adenoidectomy”, “chronic rhinosinusitis AND children AND surgical treatment”, “chronic
rhinosinusitis AND children AND endoscopic sinus surgery”, “chronic rhinosinusitis AND children
AND balloon”. The literature searched was aimed to evaluate the effectiveness of any surgical option
(i.e., adenoidectomy, BCS, and ESS), as attested by the reported success rate and related failure and
complications rates when available.
Consideration was only given to original in vivo studies published in the English language in
peer-reviewed journals and specifically concerning the role of surgery in otherwise healthy children
with CRS. Animal studies, reviews, and case series including children with systemic disease (cystic
fibrosis, primary ciliary dyskinesia, immunological defects) or adult patients were excluded.
The reference lists were subsequently reviewed to ensure that all of the selected papers were truly
relevant and to identify any that had possibly been overlooked.
3. Results
Seventeen (including ten prospective non-randomised studies, 6 retrospective studies, and one
prospective randomised study) [17–33] of the 72 initially identified papers were included in this review,
corresponding to 1930 paediatric patients.
Success rates range between 47% and 61% after adenoidectomy alone and 87–92% when combined
with other surgical procedures. Failures rates were 40–50% and 3–7%, respectively. Success rates
after BCS (with or without concomitant procedures) and ESS were 80–100% and 62–87%, respectively,
and the corresponding values for failures were 9–19% and 2–12%, respectively. Table 1 shows the main
characteristics of the selected case series and related surgical results.
3.1. Adenoidectomy
It is well known that adenoids may act as a reservoir for resistant polymicrobial bacterial biofilms
responsible for repeated acute exacerbations and recalcitrant disease in children with recurrent upper
airway infections, including rhinosinusitis [34–38]. Particularly, Zuliani et al. [38] documented,
by means of scanning electron microscopy analysis, that bacterial biofilm was present in almost all
the adenoidal specimens taken from children undergoing adenoidectomy for CRS, and it was absent
in those specimens removed from children with sleep-disordered breathing but with no history of
recurrent infections.
Therefore, adenoidectomy has been proposed as the first-line surgical approach after traditional
conservative medical treatment [17,21,39–41] in children with symptoms of CRS, being particularly
effective in younger ones, with a symptomatic relief reported in up to 80% of cases [1,21,40].
A prospective study conducted on 37 children with CRS documented the effectiveness of
adenoidectomy in reducing the number of acute exacerbations and in improving the nasal patency,
mainly in younger patients with obstructive symptoms [17]. However, it was also reported that
a positive surgical outcome was not strictly related to the grade of adenoidal hypertrophy [42,43],
and some authors found a good microbiological correspondence between adenoidal bacterial strains
and those isolated from the middle meatus [44]. This evidence once again supports biofilm theory,
thus suggesting the importance of surgical debridement of any primary biofilm-substained adenoidal
infectious focus in children with CRS.
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Table 1. Results of the included studies.
Author, Year No. of pts, Age (Years) Study Design Interventions Outcomes Complications/Failures
Ungkanont and
Damrongsak [17], 2004
37,
Mean: 6.7 ± 2.8
Prospective
single arm
Adenoidectomy
(±tonsillectomy/myringotomy and
tube insertion).
Significant reduction in the number of episodes of
acute sinusal infection.
Significant reduction in obstructive symptoms.
-
Ramadan and
Tiu [18], 2007 121
Retrospective
single arm Adenoidectomy. Successful in 50% of cases.
Failures in 50% of cases (55 pts.
Candidates to ESS, mean age 6.9 years);
Failure most frequently in children with
asthma and in ≤7 years
Ramadan and
Cost [19], 2008
60,
Mean: 6.3
Retrospective
non-randomised
Adenoidectomy (electrocautery
desiccation) with (53%) or without (47%)
maxillary sinus wash.
Symptoms * improvement more frequently in children
undergone adenoidectomy + sinus wash
(87.5% vs. 60.7%).
* nasal obstruction/congestion, purulent drainage,
cough, headache
ESS performed in two pts for failure
Ramadan and
Terrel [20], 2010
49,
Mean: 7.7
Retrospective
non-randomised BCS (61%) or adenoidectomy (39%).
Symptoms improvement * more frequently in BCS
compared to adenoidectomy (80.0% vs. 52.6%);
BCS is more effective in older pts.
* SNOT-5
-
Vandenberg and
Heatley [21], 1997
44,
Range: 1–12
Retrospective
single arm Adenoidectomy.
Complete symptomatic recovery in 58%.
Reduction in the number of pts. With rhinorrhoea,
nasal congestion, mouth breathing, antibiotic use.
ESS performed in 6.8% for failure
Deckard et al. [22], 2011 110,Mean: 3.7
Retrospective
non-randomised
Bilateral maxillary sinus aspiration
through the inferior meatus and
irrigation (MSI) with adenoidectomy
(58.2%) or endoscopically guided middle
meatus cultures (ECG) and antral biopsy
with adenoidectomy (41.8%).
Recovery in 94.6% of MSI and 92.6% of ECG.
Significant reduced time resolution of symptoms in
ECG group.
Epistaxis in 1 case (MSI, after trocar
introduction) with nasal packing;
2 pseudoproptosis with spontaneous
recovery in MSI group
Ramadan [23], 1999 61,Mean: 7.2 ± 3.1
Prospective
non-randomised
ESS * (52%) or adenoidectomy (48%).
* anterior ethmoidectomy + middle
meatal antrostomy; in 28% of cases with
posterior ethmoidectomy; in 12% of cases
with sphenoidotomy
Symptoms * improvement in 77% of pts. after ESS and
in 47% of pts. after adenoidectomy.
Improvement in nasal congestion/cough similar in
both groups.
* nasal congestion, discharge, cough, headache
Adenoidectomy performed in 3% of
cases after ESS for failure; ESS performed
in 40% of cases after adenoidectomy
for failure
Gerber and
Kennedy [24], 2018
25,
Range: 2–12
Prospective
randomised
BCS of the maxillary sinus with antral
irrigation and suction electrocautery
adenoidectomy (48%) or suction
electrocautery adenoidectomy with
maxillary antral irrigation via middle on
inferior meatus puncture (52%).
Similar improvement in QoL scores and SN-5 * scores
in all domains in both groups.
* N. of sinus infections, nasal obstruction, allergy
symptoms, emotional distress, activity limitations
-
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Author, Year No. of pts, Age (Years) Study Design Interventions Outcomes Complications/Failures
Ramadan et al. [25], 2010
32 *,
Mean; 6.5 ± 2.6
* previous adenoidectomy
in 56%.
Prospective
non-randomised
BCS * with: adenoidectomy (46.9%),
anterior ethmoidotomy (15.6%), with
antero-posterior ethmoidotomy (3.1%).
* 63 sinuses
Successful dilatation in 89% of sinuses *
Significant improvement in 50% of cases, partial
improvement in 37% of cases.
Significant improvement in mean post-operative SN-5.
* 94% of maxillary, 67% of frontal, and 57% of
sphenoid sinuses
No major complications.
Failure in 11% of cases *
* 3 hypoplastic maxillary sinuses,
3 sphenoid and 1 frontal sinuses
Ramadan [26], 2009
30 *,
Mean: 8, range: 4–16
* previous adenoidectomy
in 37%.
Prospective single
arm
BCS * (adenoidectomy by means of
suction cautery desiccation in 43%).
* 56 sinuses: 48 maxillary, 6 sphenoid,
and 2 frontal sinuses
Successful dilatation in 91% *.
* 98% of non-hypoplastic sinuses, and 60% of
hypoplastic sinuses
No major complications.
Failure in 9% of cases *
* mainly in hypoplastic sinuses
Ramadan et al. [27], 2012
26 *,
Mean: 9.0 ± 2.5
* after adenoidectomy
failure.
Prospective
non-randomised
BCS * (with: anterior ethmoidectomy in
4 pts., contralateral maxillary antrostomy
for hypoplastic sinus or failure to
cannulate in 3 pts., revision of
adenoidectomy in 2 pts.).
* 33 sinuses
Success in 81% of cases.
Significant improvement in post-operative SN-5. Failure in 19% of cases.
Soler et al. [28], 2007 50 Prospective singlearm
BCS * (combined procedures in 60%
including adenoidectomy in 42%,
inferior turbinate reduction in 26%,
ethmoidectomy in 12%).
* 157 sinuses: 98 maxillary, 30 frontal,
29 sphenoid sinuses.
Success in 100% of cases.
Significant improvement in 94% of cases.
Significant improvement in post-operative SN-5.
Minor side effects in 2 pts.
No improvement in 6% of cases.
No revision surgery performed.
Thottam et al. [29], 2012
31 *,
Mean: 9.3, range: 3–17
* previous adenoidectomy
in 13 pts.
Retrospective
non-randomised
BCS * with ethmoidectomy (15 pts.) or
ESS ** (16 pts.).
* 30 maxillary and 10 frontal sinuses.
** maxillary antrostomy in 32 sinuses +
DRAF I/IIA frontal sinusotomy in 12
frontal sinuses.
Improvement in sinus complaints * in 62.5% of pts.
after ESS and in 80% after BCS. Significant
improvement of congestion in BCS groups compared
to ESS group.
* facial pain, congestion, post-nasal drip, rhinorrhoea,
headache, nasal spray use.
No complications.
ESS performed in 1 pt. after BCS for
failure.
No improvement/worsening in 3 pts. of
BCS group and in 6% of ESS group.
Ramadan [30], 2001
83 *,
Mean: 5.98, range: 2–14.
* previous adenoidectomy
in 26 pts.
Prospective
non-randomised
ESS (anterior ethmoidectomy + maxillary
antrostomy in 112 pts., posterior
ethmoidectomy + sphenoidotomy in few
cases) with adenoidectomy (62%).
Success in 82%.
Significantly higher success rate in children ≥6 years.
Revision surgery in 11 of cases (mainly in
younger than 6 years).
Ramadan [31], 2004 202,Range: 2–13
Prospective
non-randomised
ESS with adenoidectomy * or ESS or
adenoidectomy *
* curetting and/or cauterisation
Success in 87.3% of pts. after ESS with adenoidectomy,
in 75.0% after ESS, and in 51.6% after adenoidectomy.
Best results after ESS with adenoidectomy, followed
by ESS.
Minor orbital complications * in 2.9%
of cases.
Revision surgery in 7.6% of pts. after ESS
with adenoidectomy, in 12.5 after ESS,
and in 51.6% after adenoidectomy.
* orbital entry and ecchymosis.
Jiang et al. [32], 2006 729,Range: 12–18
Prospective
single-arm ESS
Symptomatic improvement at post-operative
SNOT-20 -
Ramadan and
Hinerman [33], 2006 141
Prospective
single-arm ESS Success in 80% of pts. -
ESS: endoscopic sinus surgery; N: number; Pts: patients, BCS: balloon catheter sinuplasty; QoL: quality of life.
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However, the success rates reported in the literature after adenoidectomy performed for paediatric
CRS considerably vary, ranging between 50% and 92% [18,21,23,31,40,41,45,46], based on the case
series, different surgical approach (curette vs. endoscopic adenoidectomy), and successful outcomes
(mainly expressed as parents reporting symptomatic relief from rhinorrhoea, post-nasal drip, cough,
and nasal congestion). It has also been reported that asthmatic children and those younger than seven
years old would require more surgery sooner after adenoidectomy [31].
Given the possibility of incomplete recovery, some authors resorted to adjuvant procedures,
including middle meatal irrigation and maxillary BCS [18,20,27]. Among these, Ramadan et al. [18]
reported a better success rate of combined adenoidectomy and maxillary sinusal washes than
adenoidectomy alone in children with more severe sinus disease, but not in those with a mild
disease. Antral lavage aims both to clear maxillary secretions and collect microbiological samples to
guide focused antibiotic treatment. Some studies have found that a therapeutic protocol combining
adenoidectomy with antral lavage and long-term intravenous antibiotic treatment was superior to
adenoidectomy alone in achieving symptomatic relief [45,47]. BCS may be considered an option too:
Ramadan and Terrell [20] documented that adenoidectomy plus balloon catheter sinuplasty was more
effective than adenoidectomy alone (especially in older children) in term of symptom improvement
12 months post-operatively.
Taken together, these data suggest that, currently, simple and low-risk adenoidectomy can
still be considered a good first-line approach in refractory paediatric CRS possibly combined with
sinusal irrigations or BCS, and it should be offered before ESS, especially in younger children without
underlying predisposing factors for chronic disease. The main limitations of adenoidectomy are
related to patient selection because the procedure seems to be more effective in children younger than
6 years and in non-asthmatic ones. Additionally, the risk of adenoidal regrowth is not negligible.
Regarding surgical techniques, based on our experience with endoscopic-assisted adenoidectomy [48],
we consider this approach as the preferred modality because it achieves good surgical debridement,
with a decreased risk or persistent infectious foci. However, given that no comparative studies about
different surgical modalities have been performed, it is not possible to proclaim the superiority of any
treatment modality.
3.2. Balloon Catheter Sinuplasty (BCS)
In the last decade, BCS of the maxillary and frontal sinuses has been proposed as a minimally
invasive and safe approach for paediatric CRS, allowing the recovery of sinusal ventilation with
minimal tissue trauma because it does not require any bone or tissue removal, resulting in minimal
post-operative debris and inflammation [49]. It has been reported that the association of BCS with
adenoidectomy would enhance the effectiveness of surgery from 50% to 80% [20]. The success rate
after BCS ranges between 80 and 100% of cases, according to the case series. In many papers, BCS is
performed in combined procedures with adenoidectomy or ethmoidectomy.
In 2009, Ramadan et al. [26] reported an overall 91% success rate in a cohort of 30 children aged
4–16 years (mean age 8 years) with CRS refractory to medical treatment who underwent balloon catheter
sinuplasty combined with sinus washes; 43% of them had concurrent adenoidectomy, while 37%
had previously undergone adenoidectomy. No intra- or post-operative complications were reported,
but the procedure was not feasible in 9% of cases (including four hypoplastic maxillary sinus cases and
one frontal sinus case that was not cannulated) (success rate for non-hypoplastic sinuses: 98%; success
rate for hypoplastic sinuses: 60%).
In 2012, Ramadan et al. [27] evaluated the impact of BCS in 26 patients aged 4 to 12 years (mean
age; 7.7 years) with symptom recurrence after adenoidectomy: they reported a significant improvement
in the mean post-operative Sinus and Nasal Quality of Life Survey score, and surgical success in 81%
of cases.
More recently, Soler et al. [28] published a prospective multicentre study to evaluate the
effectiveness of BCS in 50 patients (corresponding to 157 treated sinuses, including 98 maxillary,
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30 frontal, and 29 sphenoid sinuses) aged 2 to 21 years. In 40% of cases, BSC was the only surgical
procedure; however, in the remaining patients, concurrent surgery was performed (adenoidectomy,
inferior turbinate reduction, or ethmoidectomy). Dilatation was successfully performed in all the
sinuses with no complication, and a significant clinical improvement was attested by an improvement
in the Sinus and Nasal Quality of Life Survey score in all the patients at the 6-month follow-up visit.
Thottam et al. [29] retrospectively compared the effectiveness of BCS with ESS (maxillary
antrostomy with or without frontal sinusotomy and total ethmoidectomy) and ESS alone (maxillary
antrostomy with or without frontal sinusotomy and total ethmoidectomy) in 31 children with a mean
age of 9 years: they found no difference in the overall improvement but reported a better outcome in the
BCS group in terms of the post-operative use of medications, sinus congestion and headache. On the
other hand, Gerber et al. [24] reported, in a prospective randomised trial performed on 25 children,
that the addition of BCS to adenoidectomy/maxillary sinus irrigation did not result in additional
benefits in terms of the quality of life or symptomatic improvement.
Despite this procedure seeming very attractive, especially in children, given its effectiveness and
low morbidity, the radiation exposure risk when radiography is used to confirm balloon placement
cannot be neglected, and the presence of peculiar anatomic conditions, particularly hypoplastic sinuses
or significant ethmoidal disease, might impair the results [26]. Moreover, because most studies
combined BCS with other surgical techniques and prospective randomised trials are missing, it is
unclear how much real symptomatic benefit is derived from BCS alone.
3.3. Paediatric Endoscopic Sinus Surgery for Chronic Rhinosinusitis
ESS is a safe and commonly used procedure to treat CRS in adult patients, but its use in the
paediatric population is less standardised, and most ENT surgeons are reticent in applying it in children.
In fact, approximately half of ENT specialists have reported considering adenoidectomy before PESS
to treat paediatric CRS [50].
The main concerns are related to the supposed impairment in midfacial growth after surgery
that has been suggested by animal studies [39]; however, some prospective studies failed to find
a significant effect of PESS on midfacial growth in humans [51,52]. Particularly, anthropometric
comparisons between children who had undergone PESS and controls who had received only medical
treatment documented the lack of any significant difference among the groups in terms of facial growth
10 years after [52].
Evidence supporting the effectiveness of PESS (mainly comprising maxillary antrostomy and
anterior ethmoidectomy) to treat paediatric RS is limited because published studies are mainly
retrospective and powered randomised controlled trials are lacking. However, some metanalyses
combining results obtained by available studies reported success rates ranging between 62 and 87% [8,9].
A review by Rudnik and Mitchell [53] documented that symptomatic relief after PESS may extend
a further six months post-surgically.
However, controversy persist concerning surgical indications [54]. Some authors have suggested
that all children with CRS without an immune system defect and who did not respond to both
maximal medical treatment and adenoidectomy should be candidates for PESS [23]. Others have
indicated that PESS should be proposed in children with documented structural abnormalities (such
as septal deviations or spurs, impairment in the patency of the ostiomeatal unit, and nasal polyps)
non-responding to maximal medical treatment [55]. Otherwise, other studies have failed to identify
specific subgroups of children who are more likely to benefit from PESS after failure of medical
treatment [56].
PESS is generally considered a safe procedure. However, but possible untoward effects may
infrequently occur, being reported in 0.6–1.4% of cases [8,9]. They include nasal bleeding and major
events such as orbital complications, cerebrospinal fluid leak, and meningitis. Additionally, the failure
rate cannot be neglected because it has been reported that approximately 13% of otherwise healthy
children (i.e., excluding children with cystic fibrosis, immune deficiency, and impaired ciliary activity)
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who had previously undergone ESS for CRS required revision surgery for adhesion, maxillary sinus
ostium stenosis or missed maxillary sinus ostium during primary surgery, or for the development
of contralateral disease in the non-operated sinus [26]. Moreover, it was reported that children with
asthma and those younger than six years would have a higher risk of revision surgery, suggesting
that a more conservative approach would be desirable in such a cohort of patients [26]. Therefore,
PESS can be considered an age-dependent procedure, being more effective in older children; it should
be performed by experienced surgeons given the well-known risk of rare but severe complications
and the more technical complexity of this approach in the paediatric population than in the adult
population based on the children’s smaller features.
4. Conclusions
Therapeutic management of paediatric CRS requires a stepwise approach with recourse to surgery
only after the failure of maximal medical treatment. Surgical options include adenoidectomy, antral
washes, BCS, and ESS. Although several studies have been conducted, most were retrospective and
uncontrolled, and more surgical procedures were often combined. Moreover, several studies have
been published by the same author; thus, it is not possible to exclude some overlap between case series.
Therefore, there is an urgent need for randomised controlled studies to assess the clinical benefits
derived from single surgical options.
However, given the amount of current evidence, it is reasonable to believe that, in young and
otherwise healthy children with refractory CRS, adenoidectomy (eventually combined BCS) should be
offered as the first-line surgical treatment. Nevertheless, this approach might be ineffective in some
patients who should be candidates for traditional ESS (possibly preceded by BCS if not previously
performed). In the case of peculiar conditions (older children with significant ethmoidal disease,
hypoplastic sinuses, children with underlying systemic or local predisposing factors), traditional ESS
should be considered as the primary treatment. Specific anatomic abnormalities impairing the patency
of the ostiomeatal complex should be promptly corrected (Figure 2).
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Therapeutic management of paediatric CRS requires a stepwise approach with recourse to 
surgery only after the failure of maximal medical treatment. Surgical options include 
adenoidectomy, antral washes, BCS, and ESS. Although several studies have been conducted, most 
were retrospective and uncontrolled, and more surgical procedures were often combined. Moreover, 
several studies have been published by the same author; thus, it is not possible to exclude some 
overlap between case series. Therefore, there is an urgent need for randomised controlled studies to 
assess the clinical benefits derived from single surgical options. 
o ever, given the a ount of current evidence, it is reasonable to believe that, in young and 
other ise healthy children with refractory CRS, adenoidectomy (eventually combined BCS) should 
be offered as the first-line surgical treatment. Nevertheless, this approach might be ineffective in 
some patients who should be candidates for traditional ESS (possibly preceded by BCS if not 
previously performed). In the case of peculiar conditions (older children with significant ethmoidal 
disease, hypoplastic sinuses, children with underlying systemic or local predisposing factors), 
traditional ESS should be considered as the primary treat ent. Specific anatomic abnormalities 
impairing the patency of the ostiomeatal complex should be promptly corrected (Figure 2). 
 
Figure 2. Protocol treatment. CR = chronic rhinosinusitis; BCS = balloon catheter sinuplasty; ESS = 
endoscopic sinus surgery. 
Regardless of the surgical option chosen, some failures may occur, and appropriate 
pre-operative counselling is desirable to inform the parents of the risk and advantages of each 
procedure. 
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Figure 2. Protocol treatment. CR = chronic rhinosinusitis; BCS = balloon catheter sinuplasty;
ESS = endoscopic sinus surgery.
Regardless of the surgical option chosen, some failures may occur, and appropriate pre-operative
counselling is desirable to inform the parents of the risk and advantages of each procedure.
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